AzTrials
AzTrials

Anxiety DisordersREBTonAdNCT04179526

Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems

A study testing Transdiagnostic Internet-delivered REBT in people with Anxiety Disorders and Social Anxiety Disorder, run by Babes-Bolyai University at 1 site in Romania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate the efficacy and mechanisms of change of an Internet-delivered transdiagnostic REBT intervention for adolescents with internalizing problems. Read more about this study

Who is it for?
Ages 12 to 15 years
What is being tested?
Transdiagnostic Internet-delivered REBT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
106 participants
Where
1 siteRomania
Study dates
25 Jan 2020to 30 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age between 12 and 15 years
  • A principal diagnosis of Social Anxiety Disorder, Generalized Anxiety Disorder, Panic Disorder, Persistent Depressive Disorder, or Major Depressive Disorder as defined by DSM-5 (APA, 2013)
  • Not currently following another treatment (psychotherapy, pharmacological treatment);
  • Internet access
  • Ability to read and write Romanian

Who cannot join

  • Suicidal ideation
  • Severe depression
  • Any physical and mental health acute problem that requires hospitalization
  • Diagnosed with autism spectrum disorder, psychosis, bipolar disorder or mental disability

Trial locations and contacts

1 site in 1 country.

Romania1 site
  • Babeș-Bolyai University

    Cluj-Napoca, Cluj, 400015

Other trials in Romania

About this study

Official title: The Efficacy and Mechanisms of Change of a Transdiagnostic Internet-delivered REBT Intervention for Adolescents With Internalizing Problems: A Randomized Controlled Trial

To investigate the efficacy and mechanisms of change of an Internet-delivered transdiagnostic REBT intervention for adolescents with internalizing problems.

Read the detailed description

The main objectives of this study are to evaluate the efficacy and mechanisms of change of an Internet-delivered Rational Emotive Behavior Therapy for adolescents (12-15 years) diagnosed with a principal anxiety or depressive disorder according to DSM-5 criteria. Participants will be randomly allocated to one of the two groups: experimental (REBTonAd) and waitlist control. The intervention is structured in 8 modules and will be delivered over six weeks. Assessments will be conducted at four time points: baseline, post-treatment, 3-month follow-up, and 6-month follow-up.

Being tested
Transdiagnostic Internet-delivered REBT
Keywords
transdiagnostic, anxiety, depression, REBT, adolescents, Internet intervention
Medical subject headings
Anxiety Disorders, Phobia, Social, Generalized Anxiety Disorder, Panic Disorder, Depressive Disorder, Major, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transdiagnostic Internet-delivered REBTBehavioural

    The protocol is based on Rational Emotive and Behavioral Therapy (REBT; Ellis, 1962, 1994). The program will consist of 8 modules, delivered online over six weeks.

Study groups in NCT04179526
Study groupRoleWhat they receive
Transdiagnostic Internet-delivered REBTExperimentalProtocol is based on Rational Emotive Therapy (Ellis, 1962, 1994), structured in 8 modules delivered over 6 weeks (Module 1- Introduction and psychoeducation about emotions, Module 2 - Psychoeducation anxiety and depression, Module 3 - Relaxation, Module 4 - Negative patterns of thinking and cognitive restructuring, Module 5 - Problem solving, Module 6 - Exposure and Behavioral activation, Module 7 - Positive emotions and Module 8 - Gaining maintenance)
Receives: Behavioral: Transdiagnostic Internet-delivered REBT
WaitlistNo interventionParticipants in the control group will complete pre-treatment and post-treatment assessments. After participants in the experimental group complete post-treatment assessment, they will receive the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Internalizing problems measured with the Youth Self-Report 11/18 (YSR; Achenbach & Rescorla, 2001)

    Change in self-reported internalizing problems from baseline to post-treatment, at 6 months post treatment. Higher scores indicate higher levels of internalizing problems.

    Measured: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up

Secondary outcomes (5)
  1. Automatic Thoughts QuestionnaireShort Version (ATQ-SV; Netemeyer et al., 2002)

    Change in negative automatic thoughts from baseline. Higher scores indicating higher levels of negative automatic thoughts.

    Measured: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up

  2. The child and adolescent scale of irrationality (CASI; Bernard & Cronan, 1999)

    Change in irrational beliefs from baseline. Higher scores indicate higher levels of irrational beliefs.

    Measured: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up

  3. The Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents, The Revised Version - adolescent version (Kiddo-KINDL; Ravens-Sieberer, & Bullinger, 1998)

    Change in quality of life from baseline from baseline. Higher scores indicate higher levels of quality of life.

    Measured: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up

  4. The Adolescent Peer Relations Instrument (APRI; Parada, 2000)

    Change in bullying victimization from baseline. Higher scores indicate higher levels of peer victimization.

    Measured: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up

  5. Principal diagnosis based on Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria

    Diagnostic interview for anxiety disorders and/or depressive disorders

    Measured: Baseline, 6-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2019
  2. Study start25 Jan 2020
  3. Primary completion30 May 2022
  4. Study completion30 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04179526
Sponsor's protocol ID
PN-III-P4-ID-PCE-2016-0861
Acronym
REBTonAd
Status last verified
Sep 2023
First submitted
14 Nov 2019
Last updated
13 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Dobrean A, Poetar CR, Florean IS, Balan R, Andersson G. Transdiagnostic Internet-delivered intervention for children and adolescents with anxiety and depressive disorders: a randomized controlled trial. NPJ Digit Med. 2026 Jan 16;9(1):156. doi: 10.1038/s41746-026-02341-x.

    PubMed 41545507

Questions about this trial

What is this clinical trial studying?

A study testing Transdiagnostic Internet-delivered REBT in people with Anxiety Disorders and Social Anxiety Disorder, run by Babes-Bolyai University at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Internalizing problems measured with the Youth Self-Report 11/18 (YSR; Achenbach & Rescorla, 2001) (time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04179526, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in